Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Clay

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 31, 2015
Strategic Regulatory Evaluation and Endorsement of the Hollow Fiber Tuberculosis System as a Novel Drug Development ToolKlaus Romero, Robert Clay, Debra Hanna
Biotechnology Progress|January 16, 2010
Optimization of the expression of recombinant human activin A in the yeast Pichia pastorisDale Fredericks, Robert Clay, Tracy Warner, et al.
Ebiomedicine|April 21, 2023
Metabolic role of the hepatic valine/3-hydroxyisobutyrate (3-HIB) pathway in fatty liver diseaseMona Synnøve Bjune, Laurence Lawrence-Archer, Johnny Laupsa-Borge, et al.
Nature Reviews. Clinical Oncology|June 2, 2016
Clinical development of new drug-radiotherapy combinationsRicky A Sharma, Ruth Plummer, Julie K Stock, et al.
Nature Communications|September 18, 2024
BWC0977, a broad-spectrum antibacterial clinical candidate to treat multidrug resistant infectionsShahul Hameed P, Harish Kotakonda, Sreevalli Sharma, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 31, 2015
Strategic Regulatory Evaluation and Endorsement of the Hollow Fiber Tuberculosis System as a Novel Drug Development ToolKlaus Romero, Robert Clay, Debra Hanna
Biotechnology Progress|January 16, 2010
Optimization of the expression of recombinant human activin A in the yeast Pichia pastorisDale Fredericks, Robert Clay, Tracy Warner, et al.
Ebiomedicine|April 21, 2023
Metabolic role of the hepatic valine/3-hydroxyisobutyrate (3-HIB) pathway in fatty liver diseaseMona Synnøve Bjune, Laurence Lawrence-Archer, Johnny Laupsa-Borge, et al.
Nature Reviews. Clinical Oncology|June 2, 2016
Clinical development of new drug-radiotherapy combinationsRicky A Sharma, Ruth Plummer, Julie K Stock, et al.
Nature Communications|September 18, 2024
BWC0977, a broad-spectrum antibacterial clinical candidate to treat multidrug resistant infectionsShahul Hameed P, Harish Kotakonda, Sreevalli Sharma, et al.
Pageof 1